ID: ALA80477

Max Phase: Preclinical

Molecular Formula: C12H18N3O5PS2

Molecular Weight: 379.40

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  CN1CC(CC2SCCCS2)OP1(=O)Oc1cnc(O)nc1O

Standard InChI:  InChI=1S/C12H18N3O5PS2/c1-15-7-8(5-10-22-3-2-4-23-10)19-21(15,18)20-9-6-13-12(17)14-11(9)16/h6,8,10H,2-5,7H2,1H3,(H2,13,14,16,17)

Standard InChI Key:  HKSOOROQSDOSGM-UHFFFAOYSA-N

Associated Targets(Human)

Raji 5516 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

MOLT-4F 93 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

FM3A 1296 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

L1210 27553 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 379.40Molecular Weight (Monoisotopic): 379.0425AlogP: 2.29#Rotatable Bonds: 4
Polar Surface Area: 105.01Molecular Species: NEUTRALHBA: 9HBD: 2
#RO5 Violations: 0HBA (Lipinski): 8HBD (Lipinski): 2#RO5 Violations (Lipinski): 0
CX Acidic pKa: 12.60CX Basic pKa: CX LogP: 2.33CX LogD: 2.33
Aromatic Rings: 1Heavy Atoms: 23QED Weighted: 0.76Np Likeness Score: -0.06

References

1. Kumar A, Coe PL, Jones AS, Walker RT, Balzarini J, De Clercq E..  (1990)  Synthesis and biological evaluation of some cyclic phosphoramidate nucleoside derivatives.,  33  (9): [PMID:2391680] [10.1021/jm00171a009]

Source